非小细胞,non-small cell
1)non-small cell非小细胞
1.Detection of phosphorylated AKT expression and cell proliferation in non-small cell lung cancer tissue;非小细胞肺癌组织中磷酸化AKT的表达与细胞增殖检测
2.HIF-1α,GLUT1 expression in non-small cell lung cancer (NSCLC) and their association with COX-2;非小细胞肺癌中HIF-1α、GLUT1与COX-2表达的关系
3.Expression of PTTG in non-small cell lung cancer and its relationship with PTEN and Ki-67 proteins expression;非小细胞肺癌中PTTG的表达及其与PTEN和Ki67蛋白表达的关系
英文短句/例句

1.hsa-miR-125a-5p Enhances Invasion Ability in Non-Small Lung Carcinoma Cell Lineshsa-miR-125a-5p促进非小细胞肺癌细胞侵袭
2.Gifitinib in the Treatment for 22 Cases with Advanced Non-small Cell Lung Cancer吉非替尼治疗22例晚期非小细胞肺癌
3.Research on Expression of CXCR4 in Non Small Cell Lung Cancer Cells;CXCR4在非小细胞肺癌细胞中的表达和意义
4.Differential Expression of ASPP1 and ASPP2 in Non-small-cell Lung Cancer Cell Lines;非小细胞肺癌细胞株ASPP1和ASPP2表达的检测
5.Treatment of Advanced Non-small Cell Lung Cancer by Chemotherapy Combined with Autologous Cytokine-induced Killer Cells;自体CIK细胞联合化疗治疗晚期非小细胞肺癌
6.Role on Proliferation and Invasion Potentiality of Wnt5a in Non-Small Cell Lung Cancer;Wnt5a对非小细胞肺癌细胞增殖及侵袭潜能的影响
7.An Experimental Study on T Lymphocyte Killing by Non-small-cell Lung Cancer Cells;非小细胞肺癌反杀伤T淋巴细胞的实验研究
8.The Studies on RNA Interference iASPP Gene in NSCLC Cell LinesRNA干扰非小细胞肺癌细胞iASPP基因表达的研究
9.Expression of Wip1 in non small cell lung cancer tissue and cellsWip1在非小细胞肺癌组织及细胞中的表达
10.Subcellular localization of survivin in non-small cell lung cancer非小细胞肺癌中survivin亚细胞定位的相关研究
11.Distribution and expression of bone morphogenetic protein and activin membrane-bound inhibitor in non-small-cell lung cancer cell lineBAMBI在非小细胞肺癌细胞系中的分布及表达
12.Expression and significance of CD4~+CD25~(high) regulatory T cells in patients with non-small-cell lung cancerCD4~+CD25~(high) Tr细胞在非小细胞肺癌中的表达及意义
13.Radiosensitizing effect of trichostatin A (TSA) on non-small cell lung cancer A549 cellsTSA对非小细胞肺癌A549细胞放疗增敏性的研究
14.The Isolation and Culture of Dendritic Cells Derived from EMPE in Nsclc非小细胞肺癌EMPE来源树突状细胞的分离培养
15.Study on the CD4~+CD25~+FoxP3~+ Regulatory Cells in Peripheral Blood of NSCLC Patients非小细胞肺癌外周血CD4~+CD25~+FoxP3~+调节T细胞分析
16.The Study of CD44s Expression of Lung Cancer Cells and Peripheral Blood Lymphocytes in NSCLC;非小细胞肺癌病人外周血淋巴细胞及肺癌细胞CD44s的表达研究
17.Effects of compound rhizoma smilacinus granule on the expression of P53 gene in A549 cell lines and cell cycle of non-small cell lung cancer复方菝葜颗粒对非小细胞肺癌A549细胞P53基因、细胞周期的影响
18.Expression Difference of Survivin in Cytoplasm and Nucleus in Non-small Cell Lung Cancer and its Prognostic SignificanceSurvivin在非小细胞肺癌细胞胞质和胞核的不同表达及其预后意义
相关短句/例句

non small cell非小细胞
1.CD_4~+CD_(25)~+ regulatory T cells in peripheral blood from patients with non small cell lung cancer;非小细胞肺癌患者外周血CD_4~+CD_(25)~+调节T细胞的检测及其临床意义
2.Purpose To investigate the relationship between CD44v6 expression and clinicopathologic characteristics in non small cell lung carcinomas (NSCLC).目的 探讨CD4 4v6表达与非小细胞肺癌临床病理特征之间的关系。
3.To investigate the efficacy and toxicity of combination chemotherapy with or without TAM in treatment of non small cell lung cancer.[目的]探讨全身化疗加或不加三苯氧胺对非小细胞肺癌(NSCLC)的疗效及毒性变化。
3)non-small-cell非小细胞
1.US NCCN (The National Comprehensive Cancer Network) clinical practice guidelines in oncology issued the second edition treatment programs for non-small-cell lung cancer in 2006.美国NCCN肿瘤学临床实践指南在2006年发布了第二版非小细胞肺癌治疗方案,对于规范化治疗肺癌以及提高肺癌病人生存率和生存质量有着积极的意义。
2.Primary lung cancer is the leading cause of cancer deaths in most industrialized countries, and non-small-cell lung cancer (NSCLC) accounts for 75-80% of primary lung cancer, and is refractory to conventional therapeutic modalities.原发性肺癌在许多工业化国家是主要的癌症死亡原因,其中非小细胞肺癌(NSCLC)占75~80%,并且用常规疗法很难治愈。
4)non-small cell lung非小细胞
1.The expression of vascular endothelial growth factor,CD44v6 in non-small cell lung carcinoma;非小细胞肺癌组织中血管内皮生长因子和变异型细胞间黏附分子的表达
2.Late-course three-dimensional conformal concurrent chemoradiotherapy for 31 patients with non-small cell lung carcinoma;后程三维适形同期放化疗治疗Ⅲ期非小细胞肺癌31例
3.Objective To evaluate the efficacy of combination use of paclitaxel (PTX) and cisplatin (DDP) in the treatment of advanced non-small cell lung cancer (NSCLC).①目的 观察紫杉醇 (PTX)联合顺铂 (DDP)治疗晚期非小细胞肺癌 (NSCLC)的效果。
5)non-small-cell lung非小细胞肺
1.Therapeutic evaluation of the combined chemotherapy of docetaxel and oxaliplatin in the treatment of non-small-cell lung cancer;艾素联合艾恒治疗晚期非小细胞肺癌的疗效评价
2.Inhibitors of epidermal growth factor receptor in the treatment of non-small-cell lung cancer;表皮生长因子受体抑制剂在非小细胞肺癌治疗中的应用
3.Advances in the study of precise radiotherapy for non-small-cell lung cancer;非小细胞肺癌精确放射治疗研究进展
6)non-small cell lung非小细胞肺
1.Clinicopathologic research on the expression of leptin and its fuctional receptor OB-Rb in non-small cell lung cancer;瘦素及其功能性受体OB-Rb在非小细胞肺癌表达的临床病理研究
2.The methylation status of TMS1 gene in non-small cell lung cancer and its clinical significance;非小细胞肺癌中TMS1基因甲基化检测
3.Advanced non-small cell lung cancer treated with gefitinib:Clinical analysis of 57 elderly patients;吉非替尼治疗老年晚期非小细胞肺癌57例临床分析
延伸阅读

非允许细胞分子式:CAS号:性质:(一)这是一种对限制性的致死突变株不能生长的细胞;(二)经受不住由病毒所致的溶解感染的一种细胞。